within Pharmacolibrary.Drugs.ATC.R;

model R06AX17
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 5.833333333333334e-07,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0027,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0007166666666666666,
    Tlag           = 600,            
    Vdp             = 0.0027,
    k12             = 0.06,
    k21             = 0.06
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AX17</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ketotifen is a non-competitive H1-antihistamine and mast cell stabilizer used primarily to prevent and treat allergic conditions such as allergic conjunctivitis, asthma, and rhinitis. It is approved and still used today in many countries as an oral and ophthalmic agent.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration of a single 2 mg dose.</p><h4>References</h4><ol><li><p>Yagi, N, et al., &amp; Sekikawa, H (2002). Pharmacokinetics of ketotifen fumarate after intravenous, intranasal, oral and rectal administration in rabbits. <i>Biological &amp; pharmaceutical bulletin</i> 25(12) 1614–1618. DOI:<a href=&quot;https://doi.org/10.1248/bpb.25.1614&quot;>10.1248/bpb.25.1614</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12499650/&quot;>https://pubmed.ncbi.nlm.nih.gov/12499650</a></p></li><li><p>Grahnén, A, et al., &amp; Lindström, B (1992). Pharmacokinetics of ketotifen after oral administration to healthy male subjects. <i>Biopharmaceutics &amp; drug disposition</i> 13(4) 255–262. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510130404&quot;>10.1002/bdd.2510130404</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1600111/&quot;>https://pubmed.ncbi.nlm.nih.gov/1600111</a></p></li><li><p>McFadyen, ML, et al., &amp; Ludden, TM (1997). Ketotifen pharmacokinetics in children with atopic perennial asthma. <i>European journal of clinical pharmacology</i> 52(5) 383–386. DOI:<a href=&quot;https://doi.org/10.1007/s002280050305&quot;>10.1007/s002280050305</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9272408/&quot;>https://pubmed.ncbi.nlm.nih.gov/9272408</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AX17;
